NCT01829243View on ClinicalTrials.gov

Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

FibromyalgiaNeurocognition

Interventions

DRUG

Milnacipran

DRUG

Placebo

Trial Locations (1)

27705

Duke University Medical Center / Civitan Building, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Duke University

OTHER

NCT01829243 - Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial | Biotech Hunter | Biotech Hunter